Completed PHASE2 INTERVENTIONAL 2-arm NCT00570102

Nutritional Prevention Pilot Trial for Type 1 Diabetes (MIP)

Trial to Reduce IDDM in the Genetically at Risk (TRIGR): the Pilot Study

Sponsor: Academy of Finland

Interventions A highly hydrolyzed formula A regular cow's milk based formula

Updated 6 times since 2017 Last updated: Nov 27, 2012 Started: Feb 28, 1995 Primary completion: Mar 31, 2004 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Type 1 Diabetes Mellitus and is currently completed. Academy of Finland leads this study, which shows 6 recorded versions since 1995 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Apr 2020 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Apr 2020 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Academy of Finland
Diabetes Research Foundation, Finland
European Union
Juvenile Diabetes Research Foundation
Novo Nordisk A/S
University of Helsinki

Data source: University of Helsinki

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Espoo, Finland , Helsinki, Finland , Hämeenlinna, Finland , Joensuu, Finland , Jyväskylä, Finland , Kotka, Finland , Kuopio, Finland , Lahti, Finland , Lappeenranta, Finland , Oulu, Finland and 5 more locations